- Allows for rapid adjustment of depth of analgesia1
- Provides quick emergence for neurological assessment1,2
Helps facilitate monitoring of SSEPs3*
Added characteristics of ULTIVA
- No accumulation regardless of infusion duration1
- Can be used in patients with renal or hepatic impairment1
Well-established hemodynamic profile1
Carotid endarterectomy case study
5'10'', 72 kg (159 lb)
BMI 22.86 kg/m2
- Coronary artery disease
- Chronic obstructive pulmonary disease (COPD)
Medications: statin, long-acting beta agonist (inhaled), corticosteroid (inhaled), ACE inhibitor, cardioselective beta-blocker, acetylsalicylic acid (withheld for surgery)
This case study is for illustrative and educational purposes only. The dosing regimen is specific to this case study and other regimens may vary depending on patient and procedure. Any use of this product is subject to the judgment of the practitioner in each case. Please consult the full Prescribing Information in the use of this product.
- ULTIVA [package insert]. Rockford, IL: Mylan Institutional LLC; 2016.
- Wilhelm W, Schlaich N, Harrer J, et al. Recovery and neurological examination after remifentanil-desflurane or fentanyl-desflurane anaesthesia for carotid artery surgery. Br J Anaesth. 2001;86(1):44-49.
- Samra SK, Dy EA, Welch KB, Lovely LK, Graziano GP. Remifentanil- and fentanyl-based anesthesia for intraoperative monitoring of somatosensory evoked potentials. Anesth Analg. 2001;92(6):1510-1515.